Abstract

Commentary: A Cell Line for Detection of Botulinum Neurotoxin Type B.

Highlights

  • The quest for a viable, appropriate and validatable alternative assay to the mouse LD50 potency method is something that those working in the field of botulinum toxin (BoNT) have engaged with for decades

  • The mouse assay has been used as the long-standing gold standard for BoNT identification and serotype determination and for the routine assessment and quality release of BoNT commercial product batches used for clinical treatments worldwide

  • The work of Rust and colleagues, describing an alternative cell-based assay for serotype B BoNT, presents a sound, scientifically determined methodology that could be applied to the single commercial type B product available (Rust et al, 2017)

Read more

Summary

Introduction

The quest for a viable, appropriate and validatable alternative assay to the mouse LD50 potency method is something that those working in the field of botulinum toxin (BoNT) have engaged with for decades. The work of Rust and colleagues, describing an alternative cell-based assay for serotype B BoNT, presents a sound, scientifically determined methodology that could be applied to the single commercial type B product available (Rust et al, 2017).

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.